Total Payments
$972.47
2022 Payments
$411.86
Companies
13
Transactions
39
Medicare Patients
2,578
Medicare Billing
$486,572
Payment Breakdown by Category
Food & Beverage$894.56 (92.0%)
Consulting$77.91 (8.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $894.56 | 38 | 92.0% |
| Consulting Fee | $77.91 | 1 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $272.13 | 6 | $0 (2022) |
| ViiV Healthcare Company | $132.46 | 7 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $93.51 | 6 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $86.73 | 2 | $0 (2022) |
| bioMerieux Inc | $77.91 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $66.79 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $50.43 | 3 | $0 (2022) |
| Allergan, Inc. | $40.86 | 3 | $0 (2020) |
| ABBVIE INC. | $39.84 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $35.45 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $411.86 | 14 | Gilead Sciences, Inc. ($124.64) |
| 2021 | $99.89 | 6 | JAZZ PHARMACEUTICALS INC. ($39.22) |
| 2020 | $71.50 | 4 | ViiV Healthcare Company ($39.07) |
| 2019 | $169.11 | 10 | ViiV Healthcare Company ($78.11) |
| 2018 | $133.19 | 3 | Gilead Sciences, Inc. ($108.74) |
| 2017 | $86.92 | 2 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($63.95) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/11/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: DIABETES | ||||||
| 10/04/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2022 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Devices | ||||||
| 09/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: NEUROLOGY | ||||||
| 07/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2022 | bioMerieux Inc | NephroCheck Test Kit (Device) | Consulting Fee | Cash or cash equivalent | $77.91 | General |
| Category: Diagnostics | ||||||
| 07/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: DIABETES | ||||||
| 05/31/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: NEUROLOGY | ||||||
| 05/24/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $99.83 | General |
| 02/24/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/17/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.81 | General |
| 10/05/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEUROLOGY | ||||||
| 08/04/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/22/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROLOGY | ||||||
| 04/28/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: HIV | ||||||
| 03/12/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROLOGY | ||||||
| 02/17/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: ANTIBIOTIC | ||||||
| 11/18/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/30/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: HIV | ||||||
| 09/09/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.78 | General |
| 03/05/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: HIV | ||||||
| 11/21/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 839 | 1,609 | $1.2M | $124,373 |
| 2022 | 7 | 770 | 2,079 | $894,254 | $142,911 |
| 2021 | 4 | 565 | 1,987 | $299,891 | $129,324 |
| 2020 | 3 | 404 | 1,369 | $194,200 | $89,965 |
Total Patients
2,578
Total Services
7,044
Medicare Billing
$486,572
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 315 | 879 | $444,073 | $53,233 | 12.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 112 | 290 | $279,746 | $26,769 | 9.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 182 | 198 | $188,035 | $17,134 | 9.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 119 | 123 | $220,723 | $15,816 | 7.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 111 | 119 | $44,463 | $11,421 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 223 | 1,226 | $190,132 | $67,119 | 35.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 161 | 449 | $426,786 | $35,284 | 8.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 209 | 223 | $61,083 | $21,023 | 34.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 79 | 81 | $132,232 | $12,323 | 9.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 53 | 55 | $52,153 | $4,512 | 8.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 34 | 34 | $22,268 | $1,857 | 8.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $9,599 | $793.00 | 8.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 260 | 1,635 | $204,375 | $92,491 | 45.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 266 | 306 | $70,716 | $31,316 | 44.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $21,560 | $3,430 | 15.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 24 | $3,240 | $2,086 | 64.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 194 | 1,143 | $142,875 | $65,604 | 45.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 191 | 207 | $46,575 | $21,463 | 46.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 19 | $4,750 | $2,899 | 61.0% |
About Dr. Mir Ali, MD
Dr. Mir Ali, MD is a Infectious Disease healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1053676858.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mir Ali, MD has received a total of $972.47 in payments from pharmaceutical and medical device companies, with $411.86 received in 2022. These payments were reported across 39 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($894.56).
As a Medicare-enrolled provider, Ali has provided services to 2,578 Medicare beneficiaries, totaling 7,044 services with total Medicare billing of $486,572. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease, Infectious Disease
- Location Corpus Christi, TX
- Active Since 07/08/2012
- Last Updated 12/12/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053676858
Products in Payments
- DOVATO (Drug) $110.46
- Biktarvy (Drug) $97.92
- XYWAV (Drug) $93.51
- LifeVest (Device) $86.73
- NephroCheck Test Kit (Device) $77.91
- AVYCAZ (Drug) $64.96
- XARELTO (Drug) $50.43
- ZERBAXA (Drug) $49.46
- JARDIANCE (Drug) $35.45
- GORE CARDIOFORM Septal Occluder (Device) $30.62
- Hetlioz (Drug) $24.45
- JULUCA (Drug) $22.00
- NUZYRA (Drug) $21.29
- ISENTRESS (Drug) $17.33
- DALVANCE (Drug) $15.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.